-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
Vincerx Pharma, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate for Q1 2024.
- Vincerx Pharma, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending March 31, 2024 was $2.5B.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)